The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioventix Share News (BVXP)

Share Price Information for Bioventix (BVXP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,375.00
Bid: 4,300.00
Ask: 4,450.00
Change: 0.00 (0.00%)
Spread: 150.00 (3.488%)
Open: 4,375.00
High: 4,380.00
Low: 4,375.00
Prev. Close: 4,375.00
BVXP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: New Future CEO buys GBP800,000 in shares

Fri, 19th May 2023 11:23

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

----------

Future PLC - Bath, England-based magazine publisher - Chief Executive Officer Jon Steinberg buys 90,617 shares at GBP8.86, worth GBP802,948, on Thursday. The former chief operating officer of BuzzFeed Inc became CEO of Future at the start of April, replacing long-serving Zillah Byng-Thorne.

----------

Tyman PLC - London-based door and window components supplier - Non-Executive Director Paul Withers buys 25,000 shares at GBP2.59, worth GBP64,750, on Friday.

----------

Conduit Holdings Ltd - Bermuda-based reinsurance - CEO Trevor Carvey buys 12,000 shares at average GBP5.03, worth GBP60,360, on Thursday. Now has 377,709 shares.

----------

Bioventix PLC - London-based biotechnology - Chair Ian Nicholson exercises options for 1,638 shares at 1,350p and sells all of them at 3,651.53p, worth GBP59,812, on Thursday. Still has 13,000 shares, a 0.2% stake.

----------

Luceco PLC - London-based wiring accessories, electric vehicle chargers, LED lighting and portable power products supplier - Senior Independent Non-Executive Director Pim Vervaat buys 50,000 shares at GBP1.18, worth GBP59,000, on Thursday.

----------

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Mar 2022 17:05

TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Mar 2022 11:48

Bioventix hikes interim dividend after revenue falls

(Sharecast News) - Monoclonal antibody developer and supplier Bioventix reported an 8% fall in revenue in its first half on Monday, to £4.7m.

Read more
2 Dec 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
19 Oct 2021 06:54

IN BRIEF: Bioventix lifts payout as revenue rises, but profit slips

IN BRIEF: Bioventix lifts payout as revenue rises, but profit slips

Read more
30 Mar 2021 06:58

IN BRIEF: Bioventix reports first-half fall in profit, raises dividend

IN BRIEF: Bioventix reports first-half fall in profit, raises dividend

Read more
29 Mar 2021 08:58

Bioventix revenue rises in tougher first half

(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.

Read more
3 Dec 2020 16:13

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
19 Oct 2020 14:08

IN BRIEF: Bioventix Hikes Dividend Payout As Annual Earnings Rise

IN BRIEF: Bioventix Hikes Dividend Payout As Annual Earnings Rise

Read more
1 Jul 2020 18:18

UK EXECUTIVE CHANGE SUMMARY: New CFOs At Ideagen And Bioventix

UK EXECUTIVE CHANGE SUMMARY: New CFOs At Ideagen And Bioventix

Read more
1 Jul 2020 09:40

Bioventix appoints Bruce Hiscox as chief financial officer

(Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.

Read more
31 Mar 2020 18:59

CORRECT: Bioventix Reports "Strong" Interims, Increases Dividend

CORRECT: Bioventix Reports "Strong" Interims, Increases Dividend

Read more
30 Mar 2020 14:19

Bioventix Reports "Strong" Interim Performance, Increases Dividend

Bioventix Reports "Strong" Interim Performance, Increases Dividend

Read more
28 Oct 2019 18:50

DIRECTOR DEALINGS: Bioventix Non-Exec Chair Sells GBP78,000 In Shares

DIRECTOR DEALINGS: Bioventix Non-Exec Chair Sells GBP78,000 In Shares

Read more
21 Oct 2019 11:33

Bioventix full-year revenue and profits improve

(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, reported a 6% improvement in revenue for the year on Monday, to £9.3m.

Read more
29 Mar 2019 08:31

Vitamin D antibodies drive first-half growth at Bioventix

(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.